EVALUATION OF THE PERFORMANCE OF MASEF SCORE IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) UNDER A LIPID-LOWERING MEDICATION

被引：0
|
作者：
Martinez-Arranz, Ibon [1 ]
Banales, Jesus [2 ]
Alonso, Cristina [1 ]
Mayo, Rebeca [1 ]
Arrese, Marco [3 ]
Crespo, Javier [4 ]
Noureddin, Mazen [5 ]
机构：
[1] OWL Metabol, Derio, Spain
[2] Univ Basque Country, Donostia Univ Hosp, Biodonostia Res Inst, Leioa, Spain
[3] Pontificia Univ Catolica Chile, Santiago, Chile
[4] Marques Valdecilla Univ Hosp, Univ Cantabria, IDIVAL, Santander, Spain
[5] Houston Methodist Hosp, Houston, TX USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
821
引用
收藏
页码：S619 / S620
页数：2
相关论文
共 50 条
  • [1] ACUTE PANCREATITIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES?
    Kim, Do Han
    Ko, Donghyun
    Corral, Juan E.
    Kroner, Paul T.
    Lukens, Frank
    Argueta, Pedro Palacios
    GASTROENTEROLOGY, 2024, 166 (05) : S1663 - S1664
  • [2] SEPSIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES AND HIGHER MORTALITY?
    Kim, Do Han
    Ko, Donghyun
    Argueta, Pedro Palacios
    Kroner, Paul T.
    Lukens, Frank
    Corral, Juan E.
    GASTROENTEROLOGY, 2024, 166 (05) : S1661 - S1662
  • [3] Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score
    Marti-Aguado, David
    Arnouk, Joud
    Liang, Jia-Xu
    Lara-Romero, Carmen
    Behari, Jaideep
    Furlan, Alessandro
    Jimenez-Pastor, Ana
    Ten-Esteve, Amadeo
    Alfaro-Cervello, Clara
    Bauza, Monica
    Gallen-Peris, Ana
    Gimeno-Torres, Marta
    Merino-Murgui, Victor
    Perez-Girbes, Alexandre
    Benlloch, Salvador
    Perez-Rojas, Judith
    Puglia, Victor
    Ferrandez-Izquierdo, Antonio
    Aguilera, Victoria
    Giesteira, Bruno
    Franca, Manuela
    Monton, Cristina
    Escudero-Garcia, Desamparados
    Alberich-Bayarri, Angel
    Serra, Miguel A.
    Bataller, Ramon
    Romero-Gomez, Manuel
    Marti-Bonmati, Luis
    LIVER INTERNATIONAL, 2024, 44 (01) : 202 - 213
  • [4] Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD)
    Oliveira, E. C. S. D.
    Lopes, M. A.
    Beraldo, R. F.
    Castelhano, N. S.
    Baima, J. P.
    Herrerias, G. S. P.
    Quaglio, A. E., V
    Di Stasi, L. C.
    Barbosa, W. F.
    Silva, G. F.
    Sassaki, L. Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i666 - i666
  • [5] Metabolic issues in patients with metabolic dysfunction-associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review
    Alnimer, Lynna
    Arellano, Diego
    Brombosz, Elizabeth
    Noureddin, Mazen
    LIVER TRANSPLANTATION, 2024,
  • [6] Can lipid-lowering medication reduce the prevalence of atrial fibrillation in patients with left ventricular dysfunction?
    Brian Olshansky
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 16 - 17
  • [7] Can lipid-lowering medication reduce the prevalence of atrial fibrillation in patients with left ventricular dysfunction?
    Olshansky, Brian
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (01): : 16 - 17
  • [8] IMPACT OF FIBROSIS SEVERITY ON CLINICAL AND METAGENOMIC PROFILES IN MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) PATIENTS
    Joung, Hyunchae
    Joo, Jaeryang
    Kim, KyungHwan
    Shin, Chang Hun
    Lee, Hye Won
    HEPATOLOGY, 2024, 80 : S788 - S789
  • [9] Role of Saroglitazar in the treatment of metabolic dysfunction-associated steatohepatitis (MASH) in nondiabetic patients: a prospective observational study
    Kumar, Jata Shankar
    Bhardwaz, Priyanshu
    Kar, Premashis
    JOURNAL OF HEPATOLOGY, 2024, 80 : S609 - S610
  • [10] Serum protein risk stratification score for diagnostic evaluation of metabolic dysfunction-associated steatohepatitis
    Lai, Michelle
    Dillon, Simon T.
    Gu, Xuesong
    Morhardt, Tina L.
    Xu, Yuyan
    Chan, Noel Y.
    Xiong, Beibei
    Can, Handan
    Ngo, Long H.
    Jin, Lina
    Zhang, Xuehong
    Moreira, Claudia C.
    Leite, Nathalie C.
    Villela-Nogueira, Cristiane A.
    Otu, Hasan H.
    Schattenberg, Joern M.
    Schuppan, Detlef
    Afdhal, Nezam H.
    Libermann, Towia A.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (12)
12345